Switzerland-based Lonza, the world's leading contract development and manufacturing organization (CDMO), has announced i...
German technology consulting and IT services company adesso SE and Japan-based Hitachi Digital Services have announ...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Minoryx Therapeutics and Neuraxpharm Group have announced that the European Medicines Agency’s (EMA) Committee for...
Nektar Therapeutics has initiated the first two global registrational trials in its Phase 3 ZENITH AD programme for rezp...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have reported positive Phase 2a data for vortosiran, an...
ING has examined the shifting global pharmaceutical landscape in a podcast discussion focused on China’s biotech b...
BioLineRx and Hemispherian will present preclinical data on GLIX1 at the 2026 European Society for Medical Oncology Annu...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
How does CT fit into your overall regional expansion strategy, especially in emerging markets like India and Southeast A...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
Autolomous and Cellular Origins have announced end-to-end integration of their respective platforms, bringing full autom...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and...
Eppendorf has announced that its Eppendorf Research 3 neo mechanical pipettes have received two major international awar...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biop...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
